Jiexian Ma
Huadong Hospital · Huadong Hospitai, Fudan University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jiexian Ma as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:01 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07381738 · Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative DisordersFudan University · recruiting · Epstein-Barr Virus-associated Lymphoproliferative Diseases, Chronic Active Epstein-Barr Virus Infection, EBV Associated Lymphoma · principal investigator
- Ph2NCT07362810 · G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell TransplantationFudan University · recruiting · Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB), Hematopoetic Stem Cell Transplantation, Hemato-oncologic Patients · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:01 UTC. The ranking covers the 200 most relevant of 1086 PubMed records, and a shared surname and initials can bring in a namesake. All 1086 on PubMed
- 1,719 citationsRCR 75.1
- 800 citationsRCR 30.6
- 763 citationsRCR 33.8
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.Cancer Cell · 2022462 citationsRCR 28.6
- Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment.Nat Commun · 2017325 citationsRCR 12.0
- 297 citationsRCR 13.3
- Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).Nat Commun · 2020294 citationsRCR 16.0
- 251 citationsRCR 28.5
- Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial.Lancet Gastroenterol Hepatol · 2021230 citationsRCR 17.0
- 220 citationsRCR 11.1